Home / Drug shortages / Etravirine Tablet

Etravirine Tablet — FDA Drug Shortage

To Be Discontinued — Janssen Research and Development

The FDA lists a drug shortage record for Etravirine Tablet (tablet) from Janssen Research and Development with status To Be Discontinued. The shortage was first posted on 04/28/2026.

Shortage Details

Status
To Be Discontinued
Company
Janssen Research and Development
Package NDC
59676-570-01
Dosage Form
Tablet
Presentation
Intelence, Tablet, 100 mg (NDC 59676-570-01)
Initial Posting
04/28/2026
Revised Date

FDA data resources